We are live on ! Find out more
NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $121M
1-Year Est. Return 56.89%
This Fund
S&P 500
This Quarter Est. Return
+21.99%
1 Year Est. Return
+56.89%
3 Year Est. Return
+244.35%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$59.6M
AUM Growth
-$3.82M
Cap. Flow
-$11.6M
Cap. Flow %
-19.4%
Top 10 Hldgs %
77.36%
Holding
25
New
5
Increased
–
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
LBRX
LB Pharmaceuticals
LBRX
+$4.76M
2
JOBY icon
Joby Aviation
JOBY
+$3.3M
3
ETHA
iShares Ethereum Trust ETF
ETHA
+$1.5M
4
RKLB icon
Rocket Lab Corp
RKLB
+$1.34M
5
IBIT icon
iShares Bitcoin Trust
IBIT
+$1.04M

Top Sells

Rank Stock Value
1
HRMY icon
Harmony Biosciences
HRMY
+$11.8M
2
ILMN icon
Illumina
ILMN
+$11.4M
3
RXRX icon
Recursion Pharmaceuticals
RXRX
+$364K

Sector Composition

Rank Sector Weight
1 Healthcare 87.07%
2 Industrials 8.26%
3 Materials 0.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCS icon
1
Oculis Holding
OCS
$679M
$9.05M 15.18%
514,702
– –
MDGL icon
2
Madrigal Pharmaceuticals
MDGL
$10.7B
$5.45M 9.13%
11,872
– –
ONC
3
BeOne Medicines Ltd
ONC
$32.7B
$5.36M 8.99%
15,722
– –
INCY icon
4
Incyte
INCY
$24.3B
$5.01M 8.4%
59,022
– –
RYTM icon
5
Rhythm Pharmaceuticals
RYTM
$6.79B
$4.96M 8.32%
49,120
– –
LBRX
6
LB Pharmaceuticals
LBRX
$1.14B
$4.74M 7.95%
+300,000
New +$4.76M
JOBY icon
7
Joby Aviation
JOBY
$7B
$3.51M 5.88%
+217,320
New +$3.3M
RXRX icon
8
Recursion Pharmaceuticals
RXRX
$1.59B
$2.91M 4.87%
595,287
-69,323
-10% -$364K
ASND icon
9
Ascendis Pharma A/S
ASND
$16.1B
$2.7M 4.54%
13,600
– –
LAB icon
10
Standard BioTools
LAB
$339M
$2.45M 4.11%
1,883,179
– –
ACAD icon
11
Acadia Pharmaceuticals
ACAD
$4.41B
$2.2M 3.69%
102,984
– –
ARGX icon
12
argenx
ARGX
$53.7B
$2.07M 3.46%
2,800
– –
KYMR icon
13
Kymera Therapeutics
KYMR
$8.52B
$1.75M 2.93%
30,875
– –
ETHA
14
iShares Ethereum Trust ETF
ETHA
$5.43B
$1.59M 2.67%
+50,549
New +$1.5M
RKLB icon
15
Rocket Lab Corp
RKLB
$40.7B
$1.42M 2.37%
+29,540
New +$1.34M
IBIT icon
16
iShares Bitcoin Trust
IBIT
$46.7B
$1.04M 1.74%
+15,968
New +$1.04M
RVMD icon
17
Revolution Medicines
RVMD
$40.2B
$899K 1.51%
19,253
– –
HRMY icon
18
Harmony Biosciences
HRMY
$2.02B
$745K 1.25%
27,049
-341,616
-93% -$11.8M
BCYC
19
Bicycle Therapeutics
BCYC
$269M
$534K 0.9%
68,943
– –
BOLT icon
20
Bolt Biotherapeutics
BOLT
$7.65M
$310K 0.52%
58,347
– –
TRDA icon
21
Entrada Therapeutics
TRDA
$262M
$285K 0.48%
49,082
– –
REPL icon
22
Replimune Group
REPL
$934M
$267K 0.45%
63,719
– –
RANI icon
23
Rani Therapeutics
RANI
$87.3M
$247K 0.41%
493,584
– –
BSLK
24
DELISTED
Bolt Projects Holdings
BSLK
$153K 0.26%
40,597
– –
ILMN icon
25
Illumina
ILMN
$30.9B
– –
-119,196
Closed -$11.4M

Similar funds

TCM
TT Capital Management Coto De Caza, California $121M AUM 1.94% 1-Year Est. Return
MAM
Mirabaud Asset Management London, United Kingdom $121M AUM 20.69% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
CCM
Candelo Capital Management New York $121M AUM 113.39% 1-Year Est. Return
CCM
CFO Capital Management Fairfield, Connecticut $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Nan Fung Group Holdings's Q3 2025 Portfolio in Review

As of Q3 2025, Nan Fung Group Holdings held 25 positions worth $59.6M, down 6% from $63.4M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Nan Fung Group Holdings withdrew a net $11.6M in Q3 2025, closing 1 position and reducing 2 holdings. Its most notable exit was Illumina, an estimated $11.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, down from 100% a quarter earlier, followed by Industrials and Materials.

Against the trend, Nan Fung Group Holdings opened a new position in LB Pharmaceuticals worth $4.74M.

  • Nan Fung Group Holdings's largest Q3 2025 buy was LB Pharmaceuticals: 300,000 shares worth $4.74M.
  • Nan Fung Group Holdings's biggest Q3 2025 reduction was Harmony Biosciences, cutting an estimated $11.8M.
  • Nan Fung Group Holdings fully exited Illumina in Q3 2025, selling an estimated $11.4M.
  • Nan Fung Group Holdings's ten largest holdings make up 77% of its $59.6M portfolio in Q3 2025.
  • Nan Fung Group Holdings opened 5 new positions and closed 1 in Q3 2025.
  • Nan Fung Group Holdings's portfolio value fell 6% quarter-over-quarter to $59.6M.

Based on Nan Fung Group Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.